This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1998:12 Suppl A:S121-32.

Humoral immunity to HIV, SIV, and SHIV

N L Haigwood¹, S Zolla-Pazner

Affiliations

PMID: 9632993

Review

Humoral immunity to HIV, SIV, and SHIV

N L Haigwood et al. AIDS. 1998.

. 1998:12 Suppl A:S121-32.

Authors

N L Haigwood¹, S Zolla-Pazner

Affiliation

¹ Seattle Biomedical Research Institute, WA 98121, USA.

PMID: 9632993

No abstract available

PubMed Disclaimer

Similar articles

Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A, Lifson JD, Li Z, Jia F, Mukherjee S, Adany I, Liu Z, Piatak M, Sheffer D, McClure HM, Narayan O. Kumar A, et al. Virology. 2001 Jan 5;279(1):241-56. doi: 10.1006/viro.2000.0695. Virology. 2001. PMID: 11145906
Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease.
Song B, Cayabyab M, Phan N, Wang L, Axthelm MK, Letvin NL, Sodroski JG. Song B, et al. Virology. 2004 Apr 25;322(1):168-81. doi: 10.1016/j.virol.2004.02.001. Virology. 2004. PMID: 15063126
Fc receptor but not complement binding is important in antibody protection against HIV.
Hessell AJ, Hangartner L, Hunter M, Havenith CE, Beurskens FJ, Bakker JM, Lanigan CM, Landucci G, Forthal DN, Parren PW, Marx PA, Burton DR. Hessell AJ, et al. Nature. 2007 Sep 6;449(7158):101-4. doi: 10.1038/nature06106. Nature. 2007. PMID: 17805298
Antibodies and resistance to natural HIV infection.
Nabel GJ, Sullivan NJ. Nabel GJ, et al. N Engl J Med. 2000 Oct 26;343(17):1263-5. doi: 10.1056/NEJM200010263431711. N Engl J Med. 2000. PMID: 11071680 Review. No abstract available.
CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
Yang OO. Yang OO. Trends Immunol. 2004 Mar;25(3):138-42. doi: 10.1016/j.it.2004.01.004. Trends Immunol. 2004. PMID: 15036041 Review. No abstract available.

See all similar articles

Cited by

Quintuple deglycosylation mutant of simian immunodeficiency virus SIVmac239 in rhesus macaques: robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain.
Mori K, Yasutomi Y, Ohgimoto S, Nakasone T, Takamura S, Shioda T, Nagai Y. Mori K, et al. J Virol. 2001 May;75(9):4023-8. doi: 10.1128/JVI.75.9.4023-4028.2001. J Virol. 2001. PMID: 11287551 Free PMC article.
Broad antibody mediated cross-neutralization and preclinical immunogenicity of new codon-optimized HIV-1 clade CRF02_AG and G primary isolates.
Agwale SM, Forbi JC, Notka F, Wrin T, Wild J, Wagner R, Wolf H. Agwale SM, et al. PLoS One. 2011;6(8):e23233. doi: 10.1371/journal.pone.0023233. Epub 2011 Aug 4. PLoS One. 2011. PMID: 21829720 Free PMC article.
Immune mechanisms associated with protection from vaginal SIV challenge in rhesus monkeys infected with virulence-attenuated SHIV 89.6.
Miller CJ, Abel K. Miller CJ, et al. J Med Primatol. 2005 Oct;34(5-6):271-81. doi: 10.1111/j.1600-0684.2005.00125.x. J Med Primatol. 2005. PMID: 16128922 Free PMC article. Review.
Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
Ourmanov I, Brown CR, Moss B, Carroll M, Wyatt L, Pletneva L, Goldstein S, Venzon D, Hirsch VM. Ourmanov I, et al. J Virol. 2000 Mar;74(6):2740-51. doi: 10.1128/jvi.74.6.2740-2751.2000. J Virol. 2000. PMID: 10684290 Free PMC article.
Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies.
Haigwood NL, Montefiori DC, Sutton WF, McClure J, Watson AJ, Voss G, Hirsch VM, Richardson BA, Letvin NL, Hu SL, Johnson PR. Haigwood NL, et al. J Virol. 2004 Jun;78(11):5983-95. doi: 10.1128/JVI.78.11.5983-5995.2004. J Virol. 2004. PMID: 15140996 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information